Journal Guide

Current Allergy and Asthma Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of allergy and asthma.

Current HIV Research covers all the latest and outstanding developments of HIV research by publishing original research, review articles and guest edited thematic issues. The novel pioneering work in the basic and clinical fields on all areas of HIV research covers: virus replication and gene expression, HIV assembly, virus-cell interaction, viral pathogenesis, epidemiology and transmission, anti-retroviral therapy and adherence, drug discovery, the latest developments in HIV/AIDS vaccines and animal models, mechanisms and interactions with AIDS related diseases, social and public health issues related to HIV disease, and prevention of viral infection. Periodically, the journal invites guest editors to devote an issue on a particular area of HIV research of great interest that increases our understanding of the virus and its complex interaction with the host.

This reader-friendly, broad-based resource empowers allergists and immunologists to put to good use vital clinical and research advances from throughout the world. The journal provides easy access to the very best thinking of the best minds in this dynamic, burgeoning field. Each bimonthly issue features distinguished guest editors who focus exclusively on two topics in their specialty. The journal delivers unvarnished, expert assessments of developments from the previous year—overviews found nowhere else. Insightful editorials and on-the-mark invited reviews bring readers up to speed on key subjects including mechanisms of disease, dermatology, rhinitis, and asthma.All reviews are supplemented with an indispensable section, 'References and Recommended Reading'. At the back of each volume is a 'Current World Literature' section, an exceptionally thorough bibliography culled from more than 100 top journals in the field. Both sections are completely annotated and, as an added benefit, appropriate papers are flagged for their 'special' or 'outstanding interest'.Website: www.co-allergy.com.

Current Opinion in HIV and AIDS offers full and complete coverage enabling clinicians and researchers to keep up-to-date with the vast amount of information published in the field. Insightful editorials and on-the-mark invited reviews bring readers up-to-speed on key subjects such as the T-cell in HIV infection and disease, reservoirs, host factors, HIV vaccines, antiretroviral therapy and clinical trial design.Website: www.co-hivandaids.com.

Current Opinion in Immunology is a systematic review journal that aims to provide specialists with a unique and educational platform to keep up-to-date with the expanding volume of information published in the field of immunology. It consists of 6 issues per year covering the following 12 sections, each of which is reviewed once a year:Innate immunityAntigen procesingLymphocyte developmentTumour immunologyLymphocyte activation and effector functionsVaccinesHost pathogensImmune senescenceImmunogenetics and transplantationAutoimmunityAllergy and hypersensitivityThere is also a section that changes every year to reflect hot topics in the field.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Devoted exclusively to the study of the molecular biology, biochemistry, immunology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, and new cytokines, Cytokine provides comprehensive coverage of cytokines and their receptors, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors.Special issues:Suggestions for special issue topics and guest editors can be sent to Paul Taylor, p.taylor@elsevier.comBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cytokine & Growth Factor Reviews publishes thought-provoking articles (critical reviews, state-of-the-art reviews, letters to the editor, meeting reviews) devoted to important advances in the rapidly changing fields of growth factor and cytokine research. Major emphasis is placed on the multidisciplinary significance of cytokines and growth factors in areas as diverse as signal transduction, cell growth and differentiation, embryonic development, immunology, tumorigenesis and clinical medicine.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cytotherapy is the Official Journal of the International Society for Cellular Therapy (ISCT).Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, physicians, and regulatory experts involved in cell processing and therapy.The journal's scope includes research in:Stem cell processing and transplantationCell-based therapies of malignant and non-malignant blood diseasesCancerStem cell plasticityAutoimmune diseasesImmunotherapyCongenital disordersNovel molecular therapiesGene therapyMicrovesicle biology and therapeutic application

Developmental and Comparative Immunology (DCI) is an international journal that publishes articles describing original research in all areas of immunology, including comparative aspects of immunity and the evolution and development of the immune system. Manuscripts describing studies of immune systems in both vertebrates and invertebrates are welcome. All levels of immunological investigations are appropriate: organismal, cellular, biochemical and molecular genetics, extending to such fields as aging of the immune system, interaction between the immune and neuroendocrine system and intestinal immunity.Please bookmark this URL: http:/www.elsevier.com/locate/devcompimmBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Welcome to the Centers for Disease Control and Prevention. For over 60 years, CDC has been dedicated to protecting health and promoting quality of life through the prevention and control of disease, injury, and disability. We are committed to programs that reduce the health and economic consequences of the leading causes of death and disability, thereby ensuring a long, productive, healthy life for all people.

Emerging Microbes & Infections (EMI) is a new open access, fully peer-reviewed international journal. The purpose of EMI is to provide a forum to publish a wide range of scientific reports related to emerging infectious diseases, especially with new information from developing countries where such diseases are constantly arising and being discovered regularly. It will report discoveries of emerging microbes (bacteria, viruses, fungi and other pathogens) including their previously unknown phenotypic or genotypic characteristics, as well as cutting edge information associated with microbial mechanisms of pathogenesis, immune evasion and protection, clinical presentation and outcome, drug efficacy and its resistance, epidemiology and other issues important to global health.

This journal is devoted to timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders. Specific emphasis is placed on humoral and cellular targets for natural, synthetic, and genetically engineered drugs that enhance or impair endocrine, metabolic, and immune parameters and functions. Topics related to the neuroendocrine-immune axis are given special emphasis in view of the growing interest in stress-related, inflammatory, autoimmune, and degenerative disorders. Original articles related to Immune Disorders and Drug Targeting are also considered for publication.

Excellence in medical and scientific information.A leader in the field of medical publishing for the past 20 years, John Libbey Eurotext has compiled a prestigious catalogue of books and publishes more than 60 new titles every year. A wide variety of series: scientific meeting reports, monographs and practical guides both aimed at general practioners and specialists.

The European Journal of Immunology (EJI) is a basic immunology research journal, focusing on various aspects of immunology including but not limited to antigen processing, cellular immune response, immunity to infection, immunomodulation, innate immunity, molecular immunology, leukocyte signalling, clinical immunology, and new technology. Established in 1971, the Journal has been serving the needs of the immunology community worldwide with objective enthusiasm. While mechanistic insight, which helps us better understand the workings of the immune system is of great importance for EJI, we are also interested in studies that contain thought-provoking immunological findings. HIGHLIGHTS 2010.

Experimental Parasitology emphasizes modern approaches to parasitology, including molecular biology and immunology. The journal features original research papers on the physiological, metabolic, immunologic, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships.Most downloaded papersBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Through recent research advances we are increasingly able to understand and address immune-mediated diseases. Biotechnology is yielding success in areas with a strong immunologic component, such as allergic asthma, rheumatoid arthritis, inflammatory bowel disease, psoriasis and multiple sclerosis. Nevertheless, the burden of immune-mediated diseases is still enormous, with direct and indirect costs associated with such conditions believed to exceed $100 billion in the USA alone.Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.